Chemours reported Q4 adjusted net income of $7 million, down from $14 million the previous year due to TiO2 pricing and volume challenges. Despite the decline, the figure exceeded analyst consensus es
Phillips 66/Chevron joint venture CPChem reported a $24 million Q4 loss driven by declining polyethylene prices, reversing a $351 million sequential profit.
Corteva reported a 31% year-over-year drop in Q4 adjusted EPS to 22 cents, driven by a 5% sales volume decline despite a 1% price increase.
Hexpol reported declining Q4 earnings driven by adverse currency effects, while forecasting continued uncertainty through 2026. The company aims to strengthen its market position despite expecting no
Dow Inc. reported a Q4 adjusted loss per share of 34 cents, beating estimates of a 51-cent loss, while maintaining stable volumes and margins amidst cost-cutting initiatives.
CPChem CEO confirms Qatar's Ras Laffan petrochemicals project remains on schedule, with ethylene and polyethylene plants set to commence production in 2026 amidst an expected industry rebound.
ChemBrief